Sandoz
Sandoz specializes in the development of generic and biosimilar medicines, offering more affordable versions of high-quality medicines once their key patents have expired. The company maintains a broad global portfolio comprising approximately 1,300 quality generic and biosimilar products. Sandoz has marked 80 years of antibiotic production and 20 years of biosimilar medicines development, with operations spanning multiple continents including European-based manufacturing and African market partnerships.
Medicines & products
Product list is informational, aggregated from public sources — availability is confirmed per-deal through verified offers, not public listings.
Documents & downloads
Capabilities
Facility & product gallery
Sourcing from Sandoz through PharmaGlobal
Product, quantity, destination, and documents — in any of 23 languages.
Every requirement passes a first-look review before any supplier exposure.
Price, lead time, documents, and risk — side by side in a private deal room.
Data sources: Company disclosures. Last updated June 10, 2026. Profile data is aggregated from public regulatory registries and company disclosures. PharmaGlobal provides sourcing workflow tools; participants remain responsible for their own regulatory and trade compliance. Inaccurate? Report a correction.
